ABSTRACT -Biochemical markers have played an increasingly relevant role in the assessment of neonatal asphyxia. The S100B protein is particularly important in re s e a rch conducted in this field. The purpose of this study was to underline the importance of the S100B protein in the assessment of term newborn infants with hypoxic-ischemic encephalopathy, as well as to relate it to other substances also involved in the ischemic p rocess. An assessment was made from September 2003 to October 2004 of 21 term newborn infants who developed hypoxic-ischemic encephalopathy. Samples were collected on the 1 s t and 4 t h day of life and S100B p rotein and lactate concentrations were calculated using the immune cytochemical method. A positive relationship was found between the two substances. Additionally, a comparison between the two substances showed a statistically significant correlation.
Hypoxic-ischemic encephalopathy (HIE) is a condition with great impact on the body of the newb o rn infant; being the result of perinatal asphyxia, this encephalopathy compromises several organs, in addition to causing possible sequelae such as cerebral palsy, epilepsy and mental re t a rd a t i o n 1 , 2 . Its clinical signs are the progressive involvement of neurological functions, including breathing maintenance or onset, tonus, reflexes and strength, change in consciousness and frequent seizures. According to the l i t e r a t u re, the incidence of HIE varies between 0.1-0.4% of births, with diagnosis being essentially clinical 2 , 3 . The central nervous system (CNS) involvement varies with gestational age, nature of the damage and type of treatment. Pre m a t u reinfants are known to have more injuries in deeper, periventricular are a s , while in term newborn infants injuries are mostly located in the cort i c a l -s u b c o rtical are a 2 , 4 . Depending on a complex biochemical cascade, diff e rent form s of neuronal death may occur. Several changes in anaerobic metabolism occur in case of decreased blood supply to the brain, such as glycolysis, increased concentrations of inorganic phosphates and lactate 4 , 5 . C u rre n t l y, for the diagnosis of HIE, in addition to medical history and proper neurological examination, metabolic parameters are becoming incre a s i n g l y i m p o rtant. Diagnosis methods such as EEG, CT-s c a n s , M R I and somatosensory potential are useful for pro gnosis, but not in the first 24 hours, while spectro s c o p y resonance has cost limitations 1, [6] [7] [8] . A large number of molecules are asigned a ro l e as markers of neurological injury in the presence of neonatal asphyxia. Glutamate, aspartate, lactate, ammonia, creatinine, specific kinase, NSE ( n e u ron s p ecific enolase) and other substances have already been studied in peripheral blood, umbilical cord blood, amniotic fluid and cere b rospinal fluid (CSF) 9 -1 2 . Studies that measured the concentration of S100B, the cal-cium-binding protein that prevails in astrocytes, in the CSF and blood, have shown a direct re l a t i o n s h i p with brain injury 1 3 -1 5 . Significant contributions in the a rea of perinatology, such as in the administration of nitric oxide, brain hemorrhage studies and analysis of amniotic fluid in twins have shown that S100B p rotein is useful as a brain injury marker 1 2 , 1 6 , 1 7 . Addit i o n a l l y, its prognostic role was shown when it was associated with HIE in term newborn infants and a relation with moderate and severe stages could be found 12, 18 . The goal of this study was to check if S100B protein could be used as a brain injury marker in term n e w b o rninfants who developed HIE, if its variations show different degrees of involvement and if there is any correlation with other substances, among them, lactate.
METHOD
This study is a longitudinal, prospective analysis of a sample of term newborn infants who had neonatal asphyxia and ensuing HIE born at Hospital Presidente Va rgas (HPV) and Hospital de Clínicas de Porto Alegre (HCPA) from September 2003 to October 2004. Pre m a t u re newborn infants or infants with malformation were excluded from the study.
The studied variables were gender, race, weight, number of gestations, mode of delivery, HIE degree (Sarn a t / S a rnat), clinical events and biochemical concentrations of transaminases, CPK, CK-mb and S100B. Results were analyzed using the SPSS 12.0 statistical package.
Peripheral arterial blood was collected on the first and f o u rth day of life and taken to the UFRGS biochemistry labo r a t o ry, centrifuged and stored in a freezer at -70°C until concentration analyses were perf o rmed. S100B pro t e i n quantification was perf o rmed using an immune luminometric assay (BYK -Sangtec, Dietzembach, Germany). This study was approved by the HPV Ethics Committee and by the Research and Graduate Studies Group (GPPG) at HCPA .
RESULTS
Twenty-one newborn infants with HIE were studied, with peripheral arterial blood collected on the first and fourth day of life. Out of these samples, the second blood collection was not perf o rmed in Patient 20, who died on the third day. Seven newborn infants had mild degree HIE, 6 had moderate degree HIE and 8 had severe HIE. Two infants died -9.5% -both had s e v e re HIE. Caucasian (71.4%) and male (57.1%) subjects prevailed in this sample, both also showing most of the severe HIE cases. Vaginal delivery was the prevailing mode of delivery, with 61.9% (Table 1) .
In 8 cases Cesarean section was indicated and severe HIE was found in 50% of them; however, this re l ationship was not statistically significant (p=0.424). All newborn infants had proper weight for gestational age and mother age varied from 16 to 38 years (avera g e = 2 6±8 years). All mothers re p o rted they perf o rmed prenatal care and most of them were para I; ho- w e v e r, 30% of the cases did not inform number of visits. R e g a rding medical events, seizures should be underlined, since they occurred in 52.4% of the cases. A statistically significant relationship was found between seizures and the severity of HIE (p=0.003). Apgar score at the tenth minute was statistically significant (p=0.015) when compared to the HIE degre e ( Table 2) .
T h e re were no losses in the collections perf o rm e d in the first day of life for S100B concentrations, while for lactate in 4 samples it could not be perf o rmed by hemolysis. In the fourth day, we could not get the concentrations for 2 S100B samples and for 7 lactate samples.
The biochemical analysis made with S100B (1 s t -4 t h days of life), CPK, CK-mb, GOT, GPT and lactate (1st-4 t h days of life), when compared with medical data such as weight, Apgar score, degree of HIE and seizu- res, was not statistically significant, but were above normal values (Table 3) . Acidosis could be documented in the first 6 hours of life in only 6 newborn infants (28.5%). Nevert h eless, a strong association was found between acidosis and S100B and lactate in the first day of life, respectively p=0.029 and p=0.009.
When both substances were compared in their variations, statistical significance was also found in the S100B 1 s t -4 t h days group (p=0.003) and in the lactate 1 st -4 th days group (p=0.002) (Figs 1 and 2) . Likewise, a moderate positive correlation was found (rs= 0.483) between S100B and lactate concentrations in the first day (p=0.050) (Fig 3) .
No statistically significant relationship was found between S100B and lactate with the other enzymes -GOT, GPT, CPK and CK-mb.
DISCUSSION
Badawi et al. assessed the intrapartum risk factors in newborn infants and their relationship with HIE and found that in relation to vaginal delivery, there was a two-fold increase in risk between Cesarean section and vaginal delivery with the help of i n s t ruments and the occurrence of encephalopathy 1 9 . In a study with 961 low-birth weight newborn infants relating the mode of delivery, cerebral palsy and neonatal death, they found that the only adverse factor related to vaginal delivery were changes in ultrasound findings. No significant association was found c o n c e rning the occurrence of cerebral palsy or neonatal death 20 .
When assessing the data from this study, we can see that there was a prevalence of vaginal deliveries (61.9%). Out of these vaginal deliveries, only two w e re perf o rmed with the help of instruments and in a third newborn infant a forceps was used, being then subjected to an emergency Cesarean section. These data are similar to those found by Silveira in a study carried out in the same hospital, who found 58% of vaginal deliveries in newborn infants with HIE. On the other hand, the author remarked that mode of delivery did not show any statistically significant relationship with the severity of HIE, which is in agreement with the present research study 21 .
Recent studies have shown that the Apgar score , p a rticularly a low one at 5 minutes in term newborn infants, is a specific marker for HIE complications, including seizure s 2 2 . However, seizures in newborn infants with HIE can also be related to metabolic diso rders, structural injuries or malform a t i o n 1 . In this s t u d y, seizures were found in 52.4% of patients and w e re more frequent in those with Apgar score ≤ 5 at the fifth minute and severe HIE, except for one case with Apgar score 7. The same percentage value was found by Pereira in a study with asphyxiated infants at the same neonatology service 23 .
Moster stated in his publication that a low Apgar s c o re at the fifth minute is strongly associated with subsequent death or cerebral palsy 2 2 . However, the s o u rce of many cerebral palsy cases is more re l a t e d to antenatal events. Australian studies showed that only a small part is actually related to intrapart u m h y p o x i a 7 . Recent re s e a rch data suggest that, for the most part, neuropathologic findings leading to cerebral palsy occur as a result of multifactorial phenomena that take place both during fetal development and in the neonatal period . Studies conducted at HCPA by Pereira and Silveira respectively found 35.5% and 15.8% deaths in newborn infants with H I E 2 1 , 2 3 , while in this sample the mortality rate was 9.5%. These data show a clear decrease in neonatal m o rtality in a 4-years period in our setting, re f l e c ting the result of pro g ress in early diagnosis and management of asphyxiated newborn infants.
T h o rn g re n -J e rneck et al. based on clinical and labo r a t o rydiagnosis; found 62 term asphyxiated infants in their 4-years study. Their criteria were the following: Apgar <7 at the fifth minute and umbilical art e ry acidosis (ph <7.10 and/or Base Excess >12) 1 8 . Although it should be tested in every newborn infant showing signs of asphyxia, metabolic acidemia does not define the time of hypoxia and does not correlate dire c t l y with the occurrence of cerebral palsy. When blood gas analysis is not perf o rmed in the first hour of life, that hypoxia cannot be considered the causal or contributing factor of the clinical signs that may occur l a t e r 1 , 7 , 2 1 . Additionally, many cases of severe neona-tal encephalopathy are not related to intrapart u m hypoxemia 7 .
In the analysis of this population-based sample of asphyxiated newborn infants, there were technical d i fficulties to collect blood at birth to get the umbilical cord pH, which is the most sensitive asphyxia indicator. The fact that the threshold for the blood collection was up to 6 hours after birth led to many of these patients being already under ventilation or d rug support, with the consequent change in biochemical results. However, the small number of newb o rn infants with proven acidosis did not pre v e n t this result from being significant when compare d with the biochemical analysis.
One of the main premises in the early assessment of asphyxiated newborn infants is the biochemical analysis of certain molecules. Several substances are c o n s i d e red markers of brain injury 1 , 1 0 -1 2 . Animal studies have shown that excitatory amino acids, e.g. glutamate and aspartate, are involved in the pathogenesis of brain injuries and that their agonists are extremely toxic in immature brains 9 . Lactate and lactate/piruvate concentrations can also be used as a parameter of severity in perinatal asphyxia 1 0 . Other substances are mentioned, e.g. transaminases, NSE, interleukins and ammonia 1, 10, 12, 15 .
In the present study a correlation was found with l i t e r a t u re data concerning the increase in serum concentrations of the enzymes transaminases, cre a t i n i n e kinases (CPK) and CK-mb 1 , however, this correlation was not statistically significant when compared with the degree of HIE. This is probably due to the small number of cases in this study. However, the study by Nagdyman and coworkers, with 29 cases, showed a significant diff e rence in moderate and severe HIE cases when CK-mb was analyzed in serial collections starting from the 2 nd hour of life 12 .
The introduction of electrochemical techniques has enabled a fast and accurate determination of the concentration of cellular metabolites important in the biochemical chain of asphyxia, among them piruvate and lactate. Lactate, the end product of anaerobic glycolysis is converted into piruvate when oxygen supply to tissues is re s t o red. Chou et al. 1 1 s h o w e d that determining these concentrations can be an alt e rnative quantitative method to assess hypoxia. W h e n c o m p a red with normal re f e rence values of the laboratories of hospitals in which this re s e a rch was conducted (0.33-1.33 mmol/L), a significant increase in lactate concentrations was found (1.01-9.25 mmol/ L).
The S100B protein is produced and released primarily by astrocytes in the CNS where it has trophic functions on neurons and the glia 2 4 . Several studies have already shown its role as a peripheral biochemical marker in cases of brain impairment, such as head trauma, stroke, CNS tumors, Alzheimer disease, schizophrenia, systemic lupus erythematosus 13, 15, [25] [26] [27] . How e v e r, according to Wi j n b e rger et al. due to the short half-life of S100B (25 min-2 hours) no direct causal relationship can be established with brain injury, except for acute events 1 7 . Studies with asphyxiated newb o rn infants or with intraventricular hemorrhage have shown an association with increased S100B concentrations. They have concluded that this pro t e i n should be considered as one of the brain impairm e n t markers currently available 12, 13, 28 .
T h o rn g re n -J e rneck et al. found considerably increased S100B concentrations in those term newborn infants who showed moderate and severe HIE, as well as in cases of neonatal death and cerebral palsy up to the 18 t h month. These authors collected blood samples from the 1 s t to the 4 t h day of life and the concentrations in newborn infants with HIE were decre a sing, but above average values found for the contro l s . The authors found a significant correlation between S100B concentrations on the 1 st day and acidosis 18 .
In the present study, despite the small number of cases, an association was also found between S100B and lactate concentrations on the 1 s t day with acidosis. This finding enables us to underline the import a nce of S100B in the anaerobic chain and the re s u l t i n g cell degeneration, where lactate plays a role. Howev e r, no statistically significant correlation was found between S100B concentrations and the degrees of e n c e p h a l o p a t h y. This finding, which is probably due to the small number of cases, is in disagreement with recent literature findings 1 2 , 1 8 . Additionally, the ro utine for blood sample collection in this study was not limited to the first 2 hours, which is the time a gre a t e r concentration of the S100B protein is found due to its short half-life.
N o rmal S100B re f e rence values vary with age, being greater at the neonatal period. This fact can be explained by the intense maturation activity of n e u rons and the glia at this phase of life 1 4 . Few studies were able to get a S100B concentration curve related to time of collection that would allow us to find the right time for its detection and, as a consequence, greater reliability as a biochemical marker. The authors stress that repeated collections for concentration determination should be useful to pre d i c t brain damage that might occur 12, 14, 18 .
When comparing the values found in the S100B samples in this study, we can see a significant diff e rence between samples collected on the 1 s t and 4 t h day of life. This situation is similar to those re p o rt e d in the literature 1 8 . It is clear that the possibilities of n e u ro p rotective interventions are pro g re s s i v e l y i n c reasing for all ages. It is necessary to re c o g n i z e those patients who will benefit from such interventions. Probably the study of several substances, which together could lead to an early indication of brain i n j u ry signs, would be the starting point to understand neuro p rotection. For this purpose, S100B protein has a promising future, provided it is associated with other biochemical markers and clinical data.
